BRD4 and cancer: With intensive investigations devoted to understanding the molecular mechanisms that enable the observed selectivity of CAP against cancer cells, a common sense has been achieved on the tilted redox balance as a result of external perturbation in cancer cells that lack normal antioxidant systems, rendering malignant cells more vulnerable to ROS-triggered programmed cell death [126].